Objective: To analyze whether application of autologous blood cell salvage can reduce the transfusion volume of allogeneic blood and complications of blood transfusion in offpump coronary artery bypass operations.
INTRODUCTION
In recent years, the focus on blood protection has gradually increased. The use of blood cell salvage as a blood protection procedure is very important, and at present, it is widely used clinically. The procedure involves recycling blood lost after filtration or re-infusing lost blood into the patient. The feasibility and superiority of blood cell salvage has been proven by domestic and foreign research [Jiang 2014; Milne 2015; Vonk 2013] . Improvements in technology have enabled salvaging even very low blood volumes for transfusion into patients. Moreover, with advanced operation skills, bleeding volume of off-pump coronary artery bypass graft surgery is not large. Therefore, this raises the question whether the use of a blood salvage machine for autologous blood cell salvage can reduce allogeneic blood transfusion in patients. In recent years, differing opinions on the application of autologous blood cell salvage in off-pump coronary artery bypass operation have been reported. Studies have shown that off-pump coronary artery bypass operation using blood cell salvage can reduce the risks of postoperative blood transfusion in patients [Kuss 2010 ]. In contrast, Tan et al considered the application of blood cell salvage in off-pump coronary artery bypass graft operation to be unnecessary [Tan 2012] . In this study, we assessed whether the application of blood cell salvage in off-pump coronary artery bypass graft operation can reduce allogeneic blood transfusion and transfusion complications. In addition, we evaluated the economic and social benefits of both procedures.
MATERIALS AND METHODS

General Data
One hundred and twenty patients with coronary heart disease between August 2012 and January 2013 were randomly recruited to the study. We included patients aged 40-75 years, weighing 50-90 kg, undergoing heart coronary bypass graft operation for the first time, without clinical evidence of brain, liver, lung, renal parenchymal, and heart valve diseases, with an ejection fraction of left ventricle >35% and lesions on all 3 coronary arteries, for whom grafts were the left internal mammary artery and saphenous vein, and the graft number was 3 to 6. The exclusion criteria were preoperative anemia and blood coagulation dysfunction conversion to extracorporeal circulation bypass procedure. Ultimately, 120 patients were randomly divided into either the experimental group (n = 60) or control group (n = 60). Blood cell salvage was performed for all patients in the experimental group. In addition, the volumes of salvaged autologous blood and washed red blood cells were recorded for each patient. Blood cell salvage was not performed in the control group, and a hemoglobin level less than 8 g/dL was considered the standard for all patients. This study was conducted in accordance with the Declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Henan Province People's Hospital. Written informed consent was obtained from all participants.
Anesthesia Methods
All patients were selected for general anesthesia combined with controlled hypotensive anesthesia. An oxygen mask was used for each patient and electrocardiogram and pulse oxygen saturation (SpO 2 ) were monitored. Patients' blood E108 pressures were measured and they also underwent radial artery puncture, and deep vein puncture under local anesthesia, with midazolam, etomidate, fentanyl, and rocuronium used for induction. The method also involved connecting the respirator after intubation, maintaining the partial pressure of carbon dioxide (PaCO 2 ) at 35-45 mmHg, intraoperative intravenous infusion with remifentanil and propofol, continuous or discontinuous isoflurane inhalation, additional periodical administration of vecuronium, maintaining adequate depth of anesthesia, deepened anesthesia, during cutting, and sawing the sternum. After separating the internal mammary artery, 1-1.5 mg/kg heparin was administered, maintaining ACT over 280 s. Intraoperative monitoring included invasive blood pressure, central venous pressure, heart rate, hematocrit (HCT), SpO 2 , end tidal carbon dioxide partial pressure (PetCO 2 ), blood gas analysis, temperature, and electrocardiograph. Based on hemodynamic monitoring and observations during surgery, dosage of vasoactive drugs was adjusted to maintain a stable blood pressure and heart rate. After vascular anastomosis, heparin was neutralized with protamine. After surgery, a tracheal tube was placed and the patients were transferred to the ICU with ventilator support.
Blood Cell Salvage
Blood cell salvage was performed using the Dideco Electa blood cell separator (Sorin Group, Italy) and a disposable kit. A 50 mL centrifugal cup package was chosen. As an anticoagulant fluid, a solution of 200 mg heparin in 500 mL 0.9% sodium chloride was used. The entire recovery pipeline system was prefilled with 50 mL anticoagulant fluid and then the blood loss was salvaged through the pipeline from the skin incision with a ratio of 5:1 at a negative pressure of about 150 mmHg, while washing with 600-1000 mL physiological saline each time.
Autologous Blood Transfusion
The patients were first infused with lactated Ringer's solution, Voluven, or succinylated gelatin through the peripheral or central venous routes, in order to maintain hemodynamic stability as much as possible. After the completion of the main operational steps, the salvaged washed red blood cells were transfused back into the patients. If the bleeding volume became larger, the red blood cells could still be washed and transfused back into the patient. During and after transfusion, the patient's vital signs were closely observed; all adverse reactions, such as hemoglobin urine, allergic reactions, and coagulation abnormalities, were recorded. Moreover, autologous blood transfusion volume (namely concentrated red blood cells after washed) and allogeneic blood transfusion volume were also recorded. One day after the operation, routine blood tests and biochemistry were performed; ICU retention time and complications were recorded.
Statistical Analysis
Data were analyzed by using SPSS 13.0 statistical software. The obtained data were represented as S. Comparison between groups were carried out using independent-sample t tests. P < .05 was considered significant.
RESULTS
General conditions of the 2 groups are shown in Table  1 . With respect to sex, age, weight, preoperative hemoglobin, and the number of grafts, no significant differences were found.
The mean salvaged washed red blood cell volume in the experimental group was 261.02 mL, and HCT of the washed red blood cells was 0.42-0.53, equivalent to 1.5 U suspended red blood cells.
The mean allogeneic red cell transfusion volume and plasma volume in the experimental group was 2.46 units and 266.66 mL, respectively. These results are significantly different from those of the control group, in which the mean allogeneic red cell transfusion volume and plasma volume was 4.30 units and 401.66 mL, respectively (P < .01). The incidence of complications in the experimental group was lower than in the control group. In addition, time in ICU in the experimental group was shorter than in the control group. Both differences were statistically significant (Table 2) . 
DISCUSSION
Allogeneic blood transfusion is associated with several complications and hence has received great attention from the medical community [Ong 2016; Vassal 2016] . Allogeneic blood transfusion has proven to be associated with infectious diseases, adverse reactions, and transfusion complications, which are fatal and costly [Adegoke 2011; Andreasen 2011] . Conversely, it has been suggested that autologous blood transfusion has greater effect in clinical application, and that appropriate, timely, and correct use of autologous blood transfusion technology can ensure hemodynamic stability in the perioperative period in patients with massive hemorrhage. Moreover, the use of autologous blood transfusion technology may prevent mortality at first use of the treatment, or improve opportunities for further treatment, which can reduce blood shortages, prevent the spread of diseases, reduce patient and hospital costs, improve the success rate of rescue, ensure operation efficiency, and provide positive social and economic benefits [Cholette 2013; Scott 2016] .
Studies have confirmed that coronary artery bypass grafting-related bleeding greater than 4 U should be considered an independent risk factor for mortality [Stone 2012 ]. Some authors suggested that blood cell salvage should be made a conventional measure to improve safety of off-pump coronary artery bypass surgery [Saha 2011 ]. The application of autologous blood transfusion in off-pump coronary artery bypass grafting has clinical value.
We have over 500 cases of off-pump coronary artery bypass graft operations per year in our hospital. We used the Dideco Electa blood collection blood cell separator, with a 50 mL centrifugal cup package, which allows for even a small amount of bleeding to be measured accurately and washed efficiently. The results showed that the mean salvaged washed red blood cells of the experimental group was 261.02 mL, and the HCT of the washed red cells was from 0.42 to 0.53.
The mean allogeneic red cell transfusion volume and plasma volume of the experimental group was 2.46 units and 266.66 mL, respectively. These results are significantly different from those of the control group, in which the mean allogeneic red cell transfusion volume and plasma volume was 4.30 units and 401.66 mL, respectively (P < .01). These findings suggest that the application of the intraoperative blood cell salvage machine in off-pump coronary artery bypass operation for autologous blood cell salvage, separation, and transfusion, can reduce the use of allogeneic blood in patients, and alleviate blood shortages. Moreover, complications following operation in the experimental group were significantly lower than that in the control group, which indicates that reduction of allogeneic blood transfusion can reduce postoperative complications.
With respect to costs, the per unit transfusion volume of salvaged autologous blood has a higher price than that of the corresponding allogeneic blood transfusion volume. Therefore, it will cost the patients more to undertake autologous blood cell salvage; however, patients will experience fewer complications, which will reduce intensive care unit retention time, and lead to a smaller overall cost.
Autologous blood transfusion results in the following: prevention of disease spread, reduced patient costs, reduced hospital costs, reduced blood shortage difficulties, improvement in the success rate of rescue, greater social benefits, and efficient surgery, which results in reduction of many complications associated with blood loss.
The blood cell salvage machine has been applied in the off-pump coronary artery bypass operation, in order to salvage, separate, and transfuse autologous blood. The use of this procedure can reduce allogeneic blood transfusion and postoperative complications, alleviate blood shortages, and prevent patient death due to limited blood supply. The limitations of this study were the small sample size and the absence of a postoperative long-term follow-up, both of which should be addressed in future investigations.
Conclusion
The blood cell salvage machine was applied in off-pump coronary artery bypass operation to salvage, separate, and transfuse autologous blood. The use of this procedure should be favored because it can reduce allogeneic blood transfusion and transfusion complications, leading to medical, economic, and social benefits.
